{"id":"https://openalex.org/W2005697460","doi":"https://doi.org/10.1586/14737140.2014.896207","title":"Anti-angiogenic agent ramucirumab: meaningful or marginal?","display_name":"Anti-angiogenic agent ramucirumab: meaningful or marginal?","publication_year":2014,"publication_date":"2014-03-07","ids":{"openalex":"https://openalex.org/W2005697460","doi":"https://doi.org/10.1586/14737140.2014.896207","mag":"2005697460","pmid":"https://pubmed.ncbi.nlm.nih.gov/24605771"},"language":"en","primary_location":{"id":"doi:10.1586/14737140.2014.896207","doi":"https://doi.org/10.1586/14737140.2014.896207","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737140.2014.896207","pdf_url":null,"source":{"id":"https://openalex.org/S93370067","display_name":"Expert Review of Anticancer Therapy","issn_l":"1473-7140","issn":["1473-7140","1744-8328"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anticancer Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007293979","display_name":"Roopma Wadhwa","orcid":"https://orcid.org/0000-0003-1954-0122","observed_orcids":["https://orcid.org/0000-0003-1954-0122"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roopma Wadhwa","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113167739","display_name":"Elena C. Elimova","orcid":"https://orcid.org/0009-0004-8299-7939","observed_orcids":["https://orcid.org/0009-0004-8299-7939"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Elimova","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050641993","display_name":"Hironori Shiozaki","orcid":"https://orcid.org/0000-0001-5318-7591","observed_orcids":["https://orcid.org/0000-0001-5318-7591"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hironori Shiozaki","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074229876","display_name":"Kazuki Sudo","orcid":"https://orcid.org/0000-0002-4600-9428","observed_orcids":["https://orcid.org/0000-0002-4600-9428"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kazuki Sudo","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027873506","display_name":"Mariela Anabel Blum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariela A Blum","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069988175","display_name":"Jeannelyn Santiano Estrella","orcid":"https://orcid.org/0000-0003-3705-5964","observed_orcids":["https://orcid.org/0000-0003-3705-5964"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeannelyn S Estrella","raw_affiliation_strings":["Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043074358","display_name":"Qiongrong Chen","orcid":"https://orcid.org/0000-0002-6613-535X","observed_orcids":["https://orcid.org/0000-0002-6613-535X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiongrong Chen","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068864085","display_name":"Shumei Song","orcid":"https://orcid.org/0000-0002-8128-6287","observed_orcids":["https://orcid.org/0000-0002-8128-6287"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shumei Song","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jaffer A Ajani","raw_affiliation_strings":["Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd (FC10.3022), Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044064524"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.2825,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.23626042,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"14","issue":"4","first_page":"367","last_page":"379"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.05270000174641609,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0142000000923872,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":1.0},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.8679999709129333},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/rainbow-trial","display_name":"RAINBOW trial","score":0.9810000061988831},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8659999966621399},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.8180000185966492},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.9222003221511841},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8295900821685791},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4327690899372101},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36225461959838867},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26581329107284546}],"mesh":[{"descriptor_ui":"D000096662","descriptor_name":"Ramucirumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/14737140.2014.896207","doi":"https://doi.org/10.1586/14737140.2014.896207","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737140.2014.896207","pdf_url":null,"source":{"id":"https://openalex.org/S93370067","display_name":"Expert Review of Anticancer Therapy","issn_l":"1473-7140","issn":["1473-7140","1744-8328"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anticancer Therapy","raw_type":"journal-article"},{"id":"pmid:24605771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24605771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of anticancer therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1655421535","display_name":null,"funder_award_id":"CA127672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2388979929","display_name":"Molecular Markers of Response to Chemoradiation in Localized Esophageal Cancer","funder_award_id":"R21CA127672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W157457955","https://openalex.org/W1569162089","https://openalex.org/W1884893528","https://openalex.org/W1965870971","https://openalex.org/W1971245874","https://openalex.org/W1971837077","https://openalex.org/W1978139448","https://openalex.org/W1979226579","https://openalex.org/W1992814996","https://openalex.org/W1994271665","https://openalex.org/W1995062923","https://openalex.org/W1999966467","https://openalex.org/W2000657685","https://openalex.org/W2005135215","https://openalex.org/W2005692436","https://openalex.org/W2012368323","https://openalex.org/W2017322644","https://openalex.org/W2019367792","https://openalex.org/W2022414765","https://openalex.org/W2023952988","https://openalex.org/W2052779140","https://openalex.org/W2056574134","https://openalex.org/W2068311225","https://openalex.org/W2069703793","https://openalex.org/W2073342125","https://openalex.org/W2076704022","https://openalex.org/W2079153667","https://openalex.org/W2083774542","https://openalex.org/W2094434540","https://openalex.org/W2098600061","https://openalex.org/W2100439220","https://openalex.org/W2101776780","https://openalex.org/W2102540838","https://openalex.org/W2104631255","https://openalex.org/W2104759721","https://openalex.org/W2108314670","https://openalex.org/W2109491042","https://openalex.org/W2111335459","https://openalex.org/W2111879252","https://openalex.org/W2114012800","https://openalex.org/W2114734455","https://openalex.org/W2115735904","https://openalex.org/W2119440126","https://openalex.org/W2119501407","https://openalex.org/W2122907928","https://openalex.org/W2125558775","https://openalex.org/W2129608087","https://openalex.org/W2132871418","https://openalex.org/W2135530224","https://openalex.org/W2144694316","https://openalex.org/W2146026405","https://openalex.org/W2147834058","https://openalex.org/W2149456801","https://openalex.org/W2153297361","https://openalex.org/W2155167083","https://openalex.org/W2158011521","https://openalex.org/W2158118791","https://openalex.org/W2158474413","https://openalex.org/W2160373161","https://openalex.org/W2162424705","https://openalex.org/W2164418478","https://openalex.org/W2168685702","https://openalex.org/W2170915815","https://openalex.org/W2319931547","https://openalex.org/W2326463586","https://openalex.org/W2955270635","https://openalex.org/W3139763557"],"related_works":["https://openalex.org/W2046318151","https://openalex.org/W2605594312","https://openalex.org/W2079732775","https://openalex.org/W1873923477","https://openalex.org/W2196549299","https://openalex.org/W2166625736","https://openalex.org/W3094073975","https://openalex.org/W4300418237","https://openalex.org/W2139468685","https://openalex.org/W4387809574"],"abstract_inverted_index":{"Ramucirumab":[0,4],"(IMC-1121B)":[1],"targets":[2],"VEGFR-2.":[3],"is":[5],"being":[6],"investigated":[7],"in":[8,18,38,44,53,89],"many":[9],"malignancies":[10],"including":[11,136],"gastric":[12,42],"cancer.":[13],"The":[14,31],"Phase":[15,35],"III":[16,36],"trial":[17,103],"patients":[19,39],"with":[20,40,73],"advanced":[21,41],"breast":[22],"cancer":[23,43],"failed":[24],"to":[25],"improve":[26],"the":[27,45,60,68,84,90,101,120,126],"primary":[28],"end":[29],"point":[30],"REGARD":[32],"trial,":[33],"a":[34,50],"study,":[37],"second":[46,91],"line":[47,92],"setting,":[48],"had":[49],"marginal":[51,112],"improvement":[52],"overall":[54],"survival":[55],"but":[56],"did":[57],"not":[58],"achieve":[59],"expected":[61],"hazard":[62],"ratio":[63],"target":[64],"(of":[65],"0.69)":[66],"and":[67,96,124],"median":[69],"duration":[70],"of":[71,100,122],"therapy":[72],"ramucirumab":[74,106],"was":[75],"meager":[76],"8":[77],"weeks":[78,81],"(only":[79],"2":[80],"longer":[82],"than":[83,111],"placebo's).":[85],"Other":[86],"notable":[87],"agents":[88,135],"setting":[93],"are":[94],"docetaxel":[95],"irinotecan.":[97],"Preliminary":[98],"results":[99],"RAINBOW":[102],"suggest":[104],"that":[105,130],"may":[107],"be":[108],"providing":[109],"more":[110],"advantage.":[113],"In":[114],"this":[115],"review,":[116],"we":[117],"briefly":[118],"summarize":[119],"process":[121],"angiogenesis":[123],"address":[125],"emerging":[127],"cost-benefit":[128],"issues":[129],"surround":[131],"all":[132],"newly":[133],"developed":[134],"ramucirumab.":[137]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}